Annexin Pharmaceuticals AB (publ) ANNX.ST Stock
Annexin Pharmaceuticals AB (publ) Price Chart
Annexin Pharmaceuticals AB (publ) ANNX.ST Financial and Trading Overview
Annexin Pharmaceuticals AB (publ) stock price | 0.28 SEK |
Previous Close | 1.03 SEK |
Open | 1.17 SEK |
Bid | 0.99 SEK x 0 |
Ask | 1.14 SEK x 0 |
Day's Range | 1.09 - 1.17 SEK |
52 Week Range | 0.61 - 1.41 SEK |
Volume | 1.95K SEK |
Avg. Volume | 45.45K SEK |
Market Cap | 183.72M SEK |
Beta (5Y Monthly) | 1.528352 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.26 SEK |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.9 SEK |
ANNX.ST Valuation Measures
Enterprise Value | 147.09M SEK |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 9.153226 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -3.609 |
Trading Information
Annexin Pharmaceuticals AB (publ) Stock Price History
Beta (5Y Monthly) | 1.528352 |
52-Week Change | 6.40% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.41 SEK |
52 Week Low | 0.61 SEK |
50-Day Moving Average | 1.09 SEK |
200-Day Moving Average | 1.03 SEK |
ANNX.ST Share Statistics
Avg. Volume (3 month) | 45.45K SEK |
Avg. Daily Volume (10-Days) | 52.45K SEK |
Shares Outstanding | 161.87M |
Float | 98.5M |
Short Ratio | N/A |
% Held by Insiders | 45.16% |
% Held by Institutions | 5.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -76.10% |
Return on Equity (ttm) | -144.38% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -40750000 SEK |
Net Income Avi to Common (ttm) | -41381000 SEK |
Diluted EPS (ttm) | -0.27 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 20.45M SEK |
Total Cash Per Share (mrq) | 0.13 SEK |
Total Debt (mrq) | 0 SEK |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 5.105 |
Book Value Per Share (mrq) | 0.124 |
Cash Flow Statement
Operating Cash Flow (ttm) | -42663000 SEK |
Levered Free Cash Flow (ttm) | -27071624 SEK |
Profile of Annexin Pharmaceuticals AB (publ)
Country | Sweden |
State | N/A |
City | Stockholm |
Address | Kammakargatan 48 |
ZIP | 111 60 |
Phone | N/A |
Website | https://www.annexinpharma.com/sv |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 5 |
Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden.
Q&A For Annexin Pharmaceuticals AB (publ) Stock
What is a current ANNX.ST stock price?
Annexin Pharmaceuticals AB (publ) ANNX.ST stock price today per share is 0.28 SEK.
How to purchase Annexin Pharmaceuticals AB (publ) stock?
You can buy ANNX.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Annexin Pharmaceuticals AB (publ)?
The stock symbol or ticker of Annexin Pharmaceuticals AB (publ) is ANNX.ST.
Which industry does the Annexin Pharmaceuticals AB (publ) company belong to?
The Annexin Pharmaceuticals AB (publ) industry is Biotechnology.
How many shares does Annexin Pharmaceuticals AB (publ) have in circulation?
The max supply of Annexin Pharmaceuticals AB (publ) shares is 346.58M.
What is Annexin Pharmaceuticals AB (publ) Price to Earnings Ratio (PE Ratio)?
Annexin Pharmaceuticals AB (publ) PE Ratio is now.
What was Annexin Pharmaceuticals AB (publ) earnings per share over the trailing 12 months (TTM)?
Annexin Pharmaceuticals AB (publ) EPS is -0.26 SEK over the trailing 12 months.
Which sector does the Annexin Pharmaceuticals AB (publ) company belong to?
The Annexin Pharmaceuticals AB (publ) sector is Healthcare.
Annexin Pharmaceuticals AB (publ) ANNX.ST included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}